Antithrombotic Therapy After TAVI
Recent clinical trials provide mixed messages regarding direct oral anticoagulant therapy following transcatheter aortic valve implantation.
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Doacs, spanning August 29, 2026 through September 1, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 18 article observations and 15 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
Recent clinical trials provide mixed messages regarding direct oral anticoagulant therapy following transcatheter aortic valve implantation.
Clinical trial data from ESC 2026 reveals oral anticoagulants reduce stroke risk in intermediate-risk atrial fibrillation patients.